Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Robert N Doughty"'
Autor:
Kui Tong Gerard Leong, Robert N. Doughty, Fazlur Jaufeerally, Giuseppe Vergaro, Lars Gullestad, Jay N. Cohn, Antoni Bayes-Genis, Hans-Peter Brunner-La Rocca, Michele Emdin, Lieng H. Ling, Ida Gustafsson, Michael Egstrup, Kai M. Eggers, Yasuchika Takeishi, Hanna K. Gaggin, Hean Yee Ong, Richard W. Troughton, A. Mark Richards, Thor Ueland, Inder S. Anand, James L. Januzzi, Roberto Latini, Rudolf A. de Boer, Pål Aukrust, Claudio Passino, Carolyn S.P. Lam, Alberto Aimo, Josep Lupón, Tze P. Ng, Greg D. Gamble, Kurt Huber, Poh Shuah Daniel Yeo
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of heart failure, 22(11), 2078-2088. Wiley
European Journal of Heart Failure, 22(11), 2078-2088. Wiley
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of heart failure, 22(11), 2078-2088. Wiley
European Journal of Heart Failure, 22(11), 2078-2088. Wiley
This is the peer reviewed version of the following article: Aimo, A., Januzzi, J.L., Vergaro, G., Richards, A.M., Lam, C.S.P., Latini, R. ... Emdin, M. (2020). Circulating levels and prognostic value of soluble ST2 in heart failure are less influence
Autor:
Chris J. Pemberton, Robert N. Doughty, Timothy G. Yandle, Lynley K. Lewis, Sara D Raudsepp, A. Mark Richards, Chris Frampton, Timothy C. R. Prickett
Publikováno v:
Clinical Chemistry. 65:1115-1124
BACKGROUND Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Plasma concentrations of B-type natriuretic peptide (BNP) or its amino terminal congener (NT-proBNP) are used for HF diagnosis and risk stratification. Because BNP
Autor:
A. Mark Richards, W.H. Wilson Tang, Julie A. Johnson, Stanley L. Hazen, Danilo Fliser, Heribert Schunkert, Yan Gong, Andreas Martinsson, Peter Lipp, Yi-An Ko, Stephen Zewinger, Andrej Teren, Marcus E. Kleber, Ian Ford, Sarah Triem, David J. Stott, Matthias C. Reichert, Hannah Campbell, Dawn M. Waterworth, Ulrich Laufs, Caitrin W. McDonough, Stefan Wagenpfeil, Marcin Krawczyk, Michael Böhm, J. Wouter Jukema, Naveed Sattar, Shichao Pang, Markus Scholz, Rafael Kramann, Stella Trompet, Philipp Ege, Niclas Eriksson, David Schmit, Christie M. Ballantyne, Claes Held, Marie-Pierre Dubé, Winfried März, Thimoteus Speer, Jörn Walter, Stefan James, Maxine Sun, Hooman Allayee, Lars Wallentin, Harvey D. White, Vicky A. Cameron, Stefan J Schunk, Sharon Cresci, Barbara A. Niemeyer, Susanne N. Weber, Anna P. Pilbrow, Emmanuel Ampofo, J. Gustav Smith, Sascha Tierling, Jean-Claude Tardif, Robert N. Doughty, Rhonda M. Cooper-DeHoff, Arshed A. Quyyumi, Ralph Burkhardt, John A. Spertus, Chang Liu, Eric Boerwinkle, Wolfgang Koenig, Tamim Sarakpi, Yassamin Feroz-Zada, Jaana Hartiala, Isabella Jaumann, Vinicius Tragante, Megan L. Grove
Publikováno v:
European Heart Journal, 42(18), 1742-1756. OXFORD UNIV PRESS
Aims Inflammation plays an important role in cardiovascular disease (CVD) development. The NOD-like receptor protein-3 (NLRP3) inflammasome contributes to the development of atherosclerosis in animal models. Components of the NLRP3 inflammasome pathw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546465582df71c9dc7974b0fa92a30dc
https://hdl.handle.net/1887/3246869
https://hdl.handle.net/1887/3246869
Autor:
Arthur Mark Richards, Lynley K. Lewis, Timothy G. Yandle, Chris J. Pemberton, Sara D Raudsepp, Robert N. Doughty
Publikováno v:
European Heart Journal. 41
Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Measurement of BNP and NTproBNP are used in HF for diagnosis and prognosis but levels of these peptides are inappropriately low in obesity, a condition which is as
Publikováno v:
European journal of preventive cardiology. 28(18)
Aims Cardiovascular disease (CVD) guidelines dichotomize populations into primary and secondary prevention. We sought to develop a risk equation for secondary prevention of CVD that complements existing equations for primary prevention of CVD, and to
Autor:
Bakhtawar K. Mahmoodi, W.H. Wilson Tang, Frank Dudbridge, Marcus E. Kleber, Ify R. Mordi, Naveed Sattar, Chim C. Lang, Tabassome Simon, Ruth McPherson, Aroon D. Hingorani, Nilesh J. Samani, Imo E. Hoefer, Crystel M. Gijsberts, Winfried März, Michael V. Holmes, Frank L.J. Visseren, Panos Deloukas, Johannes Waltenberger, Claes Held, Alexandre F.R. Stewart, Jaana Hartiala, Anna P. Pilbrow, Kjell Nikus, Guillaume Paré, Ekaterina V Baranova, Nicolas Danchin, Wojciech Szczeklik, Vinicius Tragante, Andrej Teren, Jari Laurikka, Gerard Pasterkamp, Mahyar Heydarpour, Diederick E. Grobbee, Emil Hagström, Kenan Direk, Daniel Levin, Mika Kähönen, Riyaz S. Patel, Hooman Allayee, Yan Gong, A. Mark Richards, Simon C. Body, Michiel L. Bots, Graciela E. Delgado, Rhonda M. Cooper-DeHoff, Thomas O. Bergmeijer, John E. Deanfield, Ragnar O. Vilmundarson, Carl J. Pepine, Julie A. Johnson, Folkert W. Asselbergs, Markus Scholz, Ralph Burkhardt, Pekka Kuukasjärvi, Olaf H. Klungel, Anke H. Maitland-van der Zee, Jochen D. Muehlschlegel, Colin N. A. Palmer, Sander W. van der Laan, Christopher P. Nelson, G. Kees Hovingh, Joachim Thiery, Jessica van Setten, Stefan James, Raymond O McCubrey, Niclas Eriksson, Stanley L. Hazen, Laurence J. Howe, John A. Spertus, Terho Lehtimäki, Salma Kotti, Robert N. Doughty, Vicky A. Cameron, Axel Åkerblom, Marcin P. Kaczor, Peter S. Braund, Petra A. Lenzini, Sharon Cresci, Lars Wallentin, Marek Sanak, Adriaan O. Kraaijeveld, Jurriën M. ten Berg, Amand F. Schmidt, Leo-Pekka Lyytikäinen
Publikováno v:
Circulation, 142, 6, pp. 546-555
Circulation
Circulation, 142(6), 546-555. Lippincott Williams and Wilkins
Circulation, 142, 546-555
Circulation, 142(6), 546. Lippincott Williams and Wilkins
Circulation
Circulation, 142(6), 546-555. Lippincott Williams and Wilkins
Circulation, 142, 546-555
Circulation, 142(6), 546. Lippincott Williams and Wilkins
Background: Studies examining the role of factor V Leiden among patients at higher risk of atherothrombotic events, such as those with established coronary heart disease (CHD), are lacking. Given that coagulation is involved in the thrombus formation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d37d30fb60ce0533239c3550d4c0acf
https://repository.ubn.ru.nl/handle/2066/235380
https://repository.ubn.ru.nl/handle/2066/235380
Autor:
Arthur Mark Richards, Timothy G. Yandle, Chris Frampton, Chris J. Pemberton, Lynley K. Lewis, Robert N. Doughty, Timothy Charles Ramsey Prickett, Sara D Raudsepp
Publikováno v:
European Heart Journal. 41
Funding Acknowledgements The National Heart Foundation of New Zealand Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Plasma levels of B-type natriuretic peptide (BNP) or its amino terminal congener (NT-proBNP)
Publikováno v:
Heart, lungcirculation. 29(9)
BACKGROUND Patients with reduced left ventricular ejection fraction (EF
Autor:
Chris Frampton, Richard W. Troughton, Robert N. Doughty, A. Mark Richards, Lorraine Skelton, Vicky A. Cameron, Chris J. Pemberton, Anna P. Pilbrow, Chris Ellis, Melinda A. Paterson, Barry R. Palmer
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254206 (2021)
PLoS ONE
PLoS ONE
Background Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performanc
Autor:
Rebecca McLean, Rachael McLean, Cliona Ni Mhurchu, Bruce Neal, Helen Eyles, Yannan Jiang, Robert N. Doughty
Publikováno v:
European Journal of Preventive Cardiology. 24:1435-1444
Background SaltSwitch is an innovative smartphone application (app) that enables shoppers to scan the barcode of a packaged food and receive an immediate, interpretive, traffic light nutrition label on the screen, along with suggestions for lower sal